Stock listing
BMV:PRCT PROCEPT BioRobotics Corporation Acciones
Mexican listing (BMV) of PROCEPT BioRobotics Corporation · home listing NASDAQ:PRCT
Follow PROCEPT BioRobotics Corporation into a list and get an email when it puts out news.
Home listing price · NASDAQ:PRCT
$24.70 USD -0.48 (-1.9%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PRCT
- Day range
- $24.64 – $26.52 USDNov 20, 2026
- Volume
- 1.04M sharesNov 20, 2026
- Market cap
- $1.42B USDAt the close on Nov 20, 2026 · price × 57.54M shares outstanding
- 52-week range
- $16.67 – $38.11 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $25.99M USDMedian day 1.19M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PRCT · Home | $24.70 USD | -0.48 (-1.9%) | 1,037,512 | $25.38 | $26.52 | $24.64 | $25.18 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRCT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $24.70 | -0.48 | -1.9% | $25.38 | $26.52 | $24.64 | 1,037,512 | |
| $25.18 | +1.40 | +5.9% | $23.66 | $25.84 | $23.55 | 2,048,401 | |
| $23.78 | +0.24 | +1.0% | $23.36 | $24.11 | $23.03 | 1,335,359 | |
| $23.54 | -0.26 | -1.1% | $23.71 | $24.29 | $23.22 | 957,956 | |
| $23.80 | +0.29 | +1.2% | $23.65 | $24.14 | $23.24 | 1,677,806 | |
| $23.51 | +0.17 | +0.7% | $23.28 | $24.31 | $23.14 | 1,347,771 | |
| $23.34 | +0.29 | +1.3% | $22.97 | $23.36 | $22.55 | 970,485 | |
| $23.05 | +0.68 | +3.0% | $22.25 | $23.44 | $21.89 | 1,789,766 | |
| $22.37 | +1.75 | +8.5% | $20.73 | $22.62 | $20.67 | 1,716,022 | |
| $20.62 | +0.35 | +1.7% | $20.14 | $20.80 | $19.41 | 1,713,534 | |
| $20.27 | -1.39 | -6.4% | $21.53 | $24.07 | $19.99 | 2,973,299 | |
| $21.66 | +1.49 | +7.4% | $20.70 | $23.19 | $20.70 | 2,822,240 | |
| $20.17 | +0.73 | +3.8% | $19.27 | $20.33 | $19.00 | 1,295,562 | |
| $19.44 | +0.24 | +1.3% | $19.33 | $19.85 | $19.09 | 1,272,049 | |
| $19.20 | -1.10 | -5.4% | $20.33 | $20.37 | $18.90 | 856,452 | |
| $20.30 | +0.10 | +0.5% | $20.41 | $20.67 | $20.06 | 704,343 | |
| $20.20 | +0.40 | +2.0% | $19.65 | $20.32 | $19.65 | 904,691 | |
| $19.80 | -0.03 | -0.2% | $19.82 | $19.91 | $19.43 | 708,661 | |
| $19.83 | -0.13 | -0.7% | $19.93 | $20.21 | $19.36 | 701,727 | |
| $19.96 | -0.07 | -0.3% | $19.90 | $20.12 | $18.75 | 773,700 | |
| $20.03 | +1.76 | +9.6% | $18.24 | $20.05 | $18.23 | 1,191,000 | |
| $18.27 | -0.55 | -2.9% | $18.54 | $18.98 | $18.12 | 733,200 | |
| $18.82 | +0.54 | +3.0% | $18.32 | $19.11 | $18.22 | 985,500 | |
| $18.28 | +0.71 | +4.0% | $17.62 | $18.32 | $17.53 | 1,013,000 | |
| $17.57 | -0.58 | -3.2% | $18.35 | $18.67 | $17.52 | 1,199,100 | |
| $18.15 | +0.64 | +3.7% | $17.58 | $18.23 | $17.58 | 1,247,800 | |
| $17.51 | -1.59 | -8.3% | $19.00 | $19.02 | $17.49 | 1,725,600 | |
| $19.10 | -0.47 | -2.4% | $19.73 | $19.87 | $18.68 | 1,814,400 | |
| $19.57 | +1.17 | +6.4% | $18.48 | $19.80 | $18.46 | 2,045,300 | |
| $18.40 | +0.50 | +2.8% | $17.78 | $18.44 | $17.78 | 1,113,900 | |
| $17.90 | -0.01 | -0.1% | $17.80 | $18.03 | $17.52 | 1,180,400 | |
| $17.91 | +0.40 | +2.3% | $17.63 | $18.46 | $17.63 | 1,149,500 | |
| $17.51 | -0.31 | -1.7% | $17.82 | $18.00 | $17.22 | 949,300 | |
| $17.82 | +0.66 | +3.8% | $17.16 | $18.09 | $17.13 | 971,000 | |
| $17.16 | +0.14 | +0.8% | $17.19 | $17.91 | $16.95 | 1,240,700 | |
| $17.02 | -1.20 | -6.6% | $18.26 | $18.46 | $16.74 | 1,604,700 | |
| $18.22 | 0.00 | 0.0% | $18.09 | $18.50 | $17.69 | 1,594,600 | |
| $18.22 | +0.97 | +5.6% | $17.37 | $18.67 | $16.80 | 2,186,700 | |
| $17.25 | +0.05 | +0.3% | $17.23 | $17.46 | $16.80 | 1,749,300 | |
| $17.20 | -0.30 | -1.7% | $17.37 | $17.69 | $17.05 | 1,952,400 | |
| $17.50 | -0.59 | -3.3% | $18.22 | $18.40 | $17.25 | 1,350,400 | |
| $18.09 | -0.34 | -1.8% | $18.34 | $18.62 | $17.95 | 914,700 | |
| $18.43 | -0.08 | -0.4% | $18.87 | $19.20 | $18.40 | 1,172,100 | |
| $18.51 | -0.79 | -4.1% | $19.31 | $19.38 | $18.41 | 1,114,500 | |
| $19.30 | -0.17 | -0.9% | $19.42 | $19.51 | $18.99 | 1,491,200 | |
| $19.47 | +0.03 | +0.2% | $19.58 | $19.58 | $19.04 | 850,000 | |
| $19.44 | +0.14 | +0.7% | $19.20 | $19.96 | $18.90 | 1,295,800 | |
| $19.30 | -1.72 | -8.2% | $20.82 | $20.91 | $19.23 | 1,997,900 | |
| $21.02 | +0.64 | +3.1% | $20.58 | $21.50 | $20.58 | 1,682,800 | |
| $20.38 | +0.31 | +1.5% | $20.23 | $20.67 | $19.55 | 1,573,200 | |
| $20.07 | -0.67 | -3.2% | $20.42 | $20.65 | $19.76 | 975,500 | |
| $20.74 | -0.61 | -2.9% | $21.22 | $21.44 | $20.60 | 1,069,600 | |
| $21.35 | -1.41 | -6.2% | $22.49 | $22.56 | $20.85 | 1,782,600 | |
| $22.76 | +1.39 | +6.5% | $21.19 | $22.84 | $20.89 | 1,275,000 | |
| $21.37 | -0.60 | -2.7% | $22.13 | $22.49 | $20.84 | 861,000 | |
| $21.97 | +1.06 | +5.1% | $20.86 | $22.09 | $20.80 | 1,277,800 | |
| $20.91 | -0.29 | -1.4% | $21.15 | $21.23 | $20.33 | 1,070,100 | |
| $21.20 | +0.37 | +1.8% | $20.76 | $21.26 | $20.38 | 939,800 | |
| $20.83 | +0.23 | +1.1% | $20.76 | $20.97 | $20.42 | 687,200 | |
| $20.60 | -0.47 | -2.2% | $21.34 | $21.34 | $20.47 | 1,107,400 | |
| $21.07 | -0.53 | -2.5% | $21.28 | $21.41 | $20.88 | 770,300 | |
| $21.60 | +0.35 | +1.6% | $21.25 | $21.67 | $21.04 | 595,427 | |
| $21.25 | -0.43 | -2.0% | $21.66 | $21.68 | $21.04 | 756,581 | |
| $21.68 | +0.95 | +4.6% | $20.77 | $22.00 | $20.77 | 821,800 | |
| $20.73 | -1.18 | -5.4% | $21.87 | $21.90 | $20.69 | 1,293,400 |
- Ticker
- BMV:PRCT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- BMV
- Currency
- MXN
What changed lately
Latest news release · Nov 18, 2026
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
Latest earnings call · Nov 4, 2026
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · May 2026
Investor Presentation (May 2026)
Investor deck · 16 slides
Latest news
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
Nov 18, 2026
Closed $24.70 (-1.9%) on Nov 20, 2026
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
Nov 4, 2026
Closed $20.27 (-6.4%) on Nov 5, 2026
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
Oct 12, 2026
Closed $19.10 (-2.4%) on Oct 13, 2026
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
Aug 17, 2026
Closed $21.09 (-2.6%) on Aug 17, 2026
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $19.34 (+5.8%) on Aug 5, 2026
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Jul 14, 2026
Closed $19.15 (-0.8%) on Jul 15, 2026
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
May 28, 2026
Closed $27.20 (+2.8%) on May 28, 2026
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
Apr 30, 2026
Closed $24.63 (+2.5%) on May 1, 2026
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
Apr 29, 2026
Closed $24.04 (+10.7%) on Apr 30, 2026
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
Apr 9, 2026
Closed $23.20 (-0.3%) on Apr 10, 2026
PROCEPT BioRobotics Corporation on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 102 in all · newest Nov 18, 2026 · oldest 2021
- Calls
- 21 calls with a replay · 21 with a transcript · latest Nov 4, 2026
- Decks
- 8 decks · latest May 2026
Where PROCEPT BioRobotics Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PRCT · Home listing | NASDAQ | United States | USD |
| BMV:PRCT · This page | BMV | Mexico | MXN |
| BIVA:PRCT | BIVA | Mexico | MXN |
| BOATS:PRCT | BOATS | United States | USD |
| BX Swiss:PRCT | BX Swiss | Switzerland | CHF |
Valuation
EV/sales 3.6× against a median of 5.1×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.25B USD
- P/E
- Loss
- EV/sales
- 3.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 4.3×
- Gross margin
- 64.7%
- Operating margin
- −33.6%
- Net margin
- −32.6%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 0.89
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation · NASDAQ:PRCT | US$1.42B | US$1.25B | n/a | 3.6× | n/a | 4.3× | −32.6% | 0.2× | 0.89 |
| Shanghai MicroPort Endovascular MedTech Co., Ltd Class A · SSE:688016 | US$1.52B | US$1.21B | 17.4× | 5.5× | n/a | 2.4× | 40.1% | 0.0× | n/a |
| Kestra Medical Technologies, Ltd. · NASDAQ:KMTS | US$1.50B | US$1.37B | n/a | 12.8× | n/a | 6.7× | −140.4% | 0.3× | 1.66 |
| Vitrolife AB · OMXSTO:VITR | US$1.49B | US$1.58B | n/a | 4.7× | n/a | 1.9× | −144.2% | 0.2× | n/a |
| Enovis Corporation · NYSE:ENOV | US$1.47B | US$2.66B | n/a | 1.1× | n/a | 1.0× | −22.9% | 0.8× | 0.95 |
| Insight Lifetech Co Ltd · SSE:688712 | US$1.47B | US$1.30B | 72.7× | 12.1× | n/a | 5.2× | 18.8% | 0.0× | n/a |
| El.En. S.p.A. · MIL:ELN | US$1.44B | US$1.25B | 30.3× | 1.9× | 12.9× | 3.2× | 7.3% | 0.0× | n/a |
| CONMED Corporation · NYSE:CNMD | US$1.39B | US$2.16B | 29.6× | 1.6× | 18.1× | 1.3× | 3.4% | 0.8× | 0.77 |
| Cofoe Medical Technology Co., Ltd. Class A · SZSE:301087 | US$1.36B | US$930.1M | 21.9× | 1.5× | n/a | 1.7× | 10.0% | 0.0× | n/a |
| Butterfly Network, Inc. · NYSE:BFLY | US$1.33B | US$1.21B | n/a | 9.8× | n/a | 7.2× | −43.6% | 0.0× | 2.86 |
| Beijing Balance Medical Technology Co. Ltd. Class A · SSE:688198 | US$1.27B | US$1.26B | 47.8× | 12.8× | n/a | 7.2× | 27.2% | 0.1× | n/a |
| Median of the others | US$1.45B | US$1.28B | 30.0× | 5.1× | 15.5× | 2.8× | 5.3% | 0.1× | 1.31 |
Forecasts
3 strong buy · 2 buy · 9 hold · 1 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 22.75 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.72 · 12 analysts
- Revenue, year to Dec 2026
- 395.3M · 14 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Larry Wood | PRESIDENT & CHIEF EXECUTIVE OFFICER |
| Kevin Waters | Executive VP, Chief Financial Officer |
| Matt Bacso | VP, Investor Relations and Business Operations |
Board
| Director | Role |
|---|---|
| Thomas M. Prescott | CHAIRMAN OF THE BOARD |
| Amy Dodrill | DIRECTOR |
| Antal Desai | DIRECTOR |
| Daniel Puckett | DIRECTOR |
| Elisabeth Little | DIRECTOR |
| Frederic Moll | DIRECTOR |
| Larry Wood | PRESIDENT & CHIEF EXECUTIVE OFFICER |
| Mary Garrett | CHAIR OF THE NOMINATING AND ESG COMMITTEE |
| Michael Mack | DIRECTOR |
| Taylor Harris | CHAIR OF THE AUDIT COMMITTEE |
Events
Calls
| Call | When | Status |
|---|---|---|
| PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2026 Earnings Call | Wed, Nov 04, 2026 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2025 Earnings Call | Wed, Feb 25, 2026 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2025 Earnings Call | Wed, Aug 06, 2025 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2025 Earnings Call | Thu, Apr 24, 2025 · 8:00 AM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2024 Earnings Call | Tue, Mar 04, 2025 · 4:30 PM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2024 Earnings Call | Mon, Oct 28, 2024 · 8:00 AM ET | Replay |
| PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 4:30 PM ET | Replay |
All 21 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 4, 2026 · After close | −6.4% |
| Q2 2026 | Aug 4, 2026 · After close | +5.8% |
| Q1 2026 | Apr 29, 2026 · After close | +10.7% |
| Q4 2025 | Mar 3, 2026 | +2.5% |
| Q3 2025 | Nov 4, 2025 · After close | −9.7% |
| Q2 2025 | Aug 6, 2025 · After close | −13.3% |
| Q1 2025 | Apr 24, 2025 · Before open | −5.6% |
| Q4 2024 | Feb 25, 2025 · After close | +8.6% |
| Q3 2024 | Oct 28, 2024 · Before open | +32.3% |
| Q2 2024 | Aug 1, 2024 · After close | −7.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 1, 2024 · Before open | +14.4% |
| Q4 2023 | Feb 27, 2024 · After close | −2.7% |
| Q3 2023 | Nov 1, 2023 · After close | +18.4% |
| Q2 2023 | Jul 27, 2023 · Before open | −7.1% |
| Q1 2023 | Apr 27, 2023 · Before open | −25.3% |
| Q4 2022 | Feb 28, 2023 · After close | +1.0% |
| Q3 2022 | Nov 4, 2022 · After close | −1.5% |
| Q2 2022 | Aug 5, 2022 · After close | −0.1% |
| Q1 2022 | May 5, 2022 · After close | +0.5% |
| Q4 2021 | Mar 8, 2022 · Before open | +6.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2026) | Investor deck | 16 slides | May 2026 |
| Investor Presentation (May 2026) | Investor deck | 16 slides | May 2026 |
| Q4 2025 Earnings Presentation | Earnings | 102 slides | Feb 25, 2026 |
| Investor Day (April 2025) | Investor day | 73 slides | Apr 25, 2025 |
| Investor Day (May 2024) | Investor day | 58 slides | May 3, 2024 |
| Investor Day (April 2023) | Investor day | 44 slides | Apr 28, 2023 |
| Investor Day (May 2022) | Investor day | 51 slides | May 13, 2022 |
| 46th Annual William Blair Growth Stock Conference | Conference | 27 slides |
IPO
Priced at US$25.00 a share on Sep 14, 2021.
- Price
- US$25.00 a share
- Shares offered
- 6,556,000 shares of common stock
- Offering size
- US$163.9 million
- Underwriters' option
- Up to 983,400 more shares
- Listing
- PRCT on the Nasdaq Global Market
- Underwriters
- BofA Securities, Goldman Sachs & Co. LLC, Cowen, Guggenheim Securities, SVB Leerink · In the order on the cover
- Shares delivered
- On or about Sep 17, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 25, 2021 |
| Filed publicly | Aug 18, 2021 |
| Amended once | Sep 8, 2021 |
| Shares registered with an exchange | Sep 10, 2021 |
| Declared effective by the SEC | Sep 14, 2021 |
| Final prospectus, with the price | Sep 16, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 16, 2021 |
| EFFECT · Notice that a registration is effective | Sep 14, 2021 |
| S-1MEF · Registration of more shares for the same offering | Sep 14, 2021 |
| CERT · Exchange's certificate of listing | Sep 14, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 10, 2021 |
| CORRESP · Letter to the SEC | Sep 10, 2021 |
| CORRESP · Letter to the SEC | Sep 10, 2021 |
| CORRESP · Letter to the SEC | Sep 8, 2021 |
| S-1/A · Registration statement, amended | Sep 8, 2021 |
| UPLOAD · Letter from the SEC | Sep 2, 2021 |
All 18 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Aug 31, 2021 |
| CORRESP · Letter to the SEC | Aug 18, 2021 |
| S-1 · Registration statement | Aug 18, 2021 |
| UPLOAD · Letter from the SEC | Aug 16, 2021 |
| DRS/A · Draft registration statement, amended | Jul 30, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jul 29, 2021 |
| UPLOAD · Letter from the SEC | Jul 23, 2021 |
| DRS · Draft registration statement | Jun 25, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 16, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 308.1M | 224.5M | 136.2M | 75.0M | 34.5M | 7.72M | 6.17M |
| Cost of revenue | 111.8M | 87.4M | 65.1M | 37.9M | 18.6M | 8.97M | 8.05M |
| Gross profit | 196.2M | 137.1M | 71.0M | 37.1M | 15.9M | -1.25M | -1.89M |
| Research and development | 71.3M | 62.3M | 48.4M | 29.0M | 19.0M | 16.3M | 13.1M |
| Selling, general and administrative | 228.8M | 171.4M | 131.8M | 88.8M | 51.0M | 30.3M | 28.5M |
| Operating income | -103.9M | -96.6M | -109.2M | -80.7M | -54.2M | -47.8M | -43.5M |
| Depreciation and amortization | 6.39M | 5.23M | 3.81M | 2.84M | 3.32M | 2.86M | 1.49M |
| EBITDA | -97.5M | -91.4M | -105.4M | -77.9M | -50.8M | -44.9M | -42.1M |
| Interest expense | 3.59M | 4.18M | 4.00M | 5.18M | 5.81M | 5.26M | 724.0K |
| Income before tax | -95.4M | -91.0M | -105.8M | -87.2M | -59.9M | -53.0M | -42.0M |
| Income tax | 190.0K | 368.0K | 80.0K | 0 | 0 | 0 | 678.0K |
| Net income | -95.6M | -91.4M | -105.9M | -87.2M | -59.9M | -53.0M | -42.0M |
| Earnings per share, basic | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 | -14.47 | -1.25 |
| Earnings per share, diluted | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 | -14.47 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 286.5M | 333.7M | 257.2M | 221.9M | 304.3M | 100.1M | 42.0M |
| Receivables | 83.5M | 83.5M | 48.4M | 15.3M | 4.46M | 1.55M | 1.10M |
| Inventory | 70.7M | 56.2M | 39.8M | 28.5M | 13.1M | 6.92M | 6.69M |
| Current assets | 450.4M | 481.8M | 350.6M | 272.6M | 326.2M | 110.3M | 50.4M |
| Property, plant and equipment | 30.4M | 26.7M | 28.7M | 8.66M | 5.04M | 8.27M | 8.27M |
| Total assets | 508.1M | 534.0M | 404.7M | 309.3M | 337.0M | 126.0M | 62.0M |
| Accounts payable | 17.3M | 10.0M | 13.5M | 9.39M | 2.03M | 1.24M | 1.44M |
| Current liabilities | 65.8M | 53.1M | 45.9M | 35.3M | 16.2M | 14.5M | 6.79M |
| Long-term debt | 51.6M | 51.5M | 51.3M | 51.2M | 50.0M | 44.4M | 23.2M |
| Total debt | 51.6M | 51.5M | 51.3M | 51.2M | 50.0M | 49.0M | 23.2M |
| Total liabilities | 142.2M | 131.8M | 124.0M | 112.3M | 69.9M | 65.0M | 32.8M |
| Shareholders' equity | 365.9M | 402.2M | 280.8M | 197.1M | 267.1M | -182.9M | 29.2M |
| Shares outstanding | 56.3M | 54.7M | 50.8M | 44.8M | 43.7M | 4.71M | 33.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -49.0M | -99.2M | -108.0M | -80.4M | -57.3M | -48.3M | -43.8M |
| Capital spending | -9.36M | -4.41M | -25.2M | -2.65M | -592.0K | -233.0K | -7.61M |
| Free cash flow | -58.3M | -103.6M | -133.2M | -83.0M | -57.9M | -48.6M | -51.4M |
| Cash from investing | -9.36M | -4.41M | -25.2M | -2.65M | -592.0K | -233.0K | 43.2M |
| Cash from financing | 11.2M | 180.1M | 167.8M | 3.61M | 262.1M | 106.8M | 26.5M |
| Share buybacks | 6.36M | 4.53M | 3.61M | 2.41M | 177.4M | ||
| Change in cash | -47.2M | 76.5M | 34.6M | -79.4M | 204.2M | 58.2M | 25.9M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 6, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 2, 2026 | Management or board change | SEC |
| 8-K · Current report | Sep 24, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 9, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 9, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 9, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 10, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| SD · Specialized disclosure | Jun 1, 2026 | ESG report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 18, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Apr 30, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Apr 30, 2026 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 29, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Apr 24, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 22, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 22, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 17, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 5, 2026 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Feb 26, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Current report | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 25, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 11, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 8, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| 8-K · Current report | Sep 18, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 8-K · Current report | Jul 24, 2025 | Results | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 10, 2025 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | Jun 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 3, 2025 | Other filings | SEC |
| SD · Specialized disclosure | May 29, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 2, 2025 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 25, 2025 | Current report | SEC |
| 8-K · Current report | Apr 24, 2025 | Results | SEC |
| 10-K/A · Annual report, amended | Apr 11, 2025 | Annual report | SEC |
| 4 · Change in ownership | Mar 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 6, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 28, 2025 | Offer document | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 4, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 4, 2024 | Other filings | SEC |
| 4 · Change in ownership | Dec 2, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 27, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 22, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 20, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 15, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Nov 13, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 7, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 4, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 31, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 31, 2024 | Current report | SEC |
| 424B5 · Prospectus | Oct 30, 2024 | Offer document | SEC |
| 424B5 · Prospectus | Oct 28, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Oct 28, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 28, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 16, 2024 | Other filings | SEC |
| 4 · Change in ownership | Sep 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 4, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 3, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 23, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 21, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 2, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2024 | Results | SEC |
| 4 · Change in ownership | Jul 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 19, 2024 | Management or board change | SEC |
| 10-Q/A · Quarterly report, amended | Jun 27, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 17, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 10, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2024 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 29, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 22, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | May 22, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | May 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | May 7, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | May 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 3, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 3, 2024 | Other filings | SEC |
| 8-K · Current report | May 3, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 2, 2024 | Quarterly report | SEC |
| 144 · Notice of proposed sale | May 1, 2024 | Other filings | SEC |
| 8-K · Current report | May 1, 2024 | Results | SEC |
| DEF 14A · Proxy statement | Apr 22, 2024 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Apr 22, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 19, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 19, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Apr 19, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Mar 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2024 | Insider trade | SEC |
This page holds 200 of 399 filings. Open Filings
Cap table
Built by 6ix from PROCEPT BioRobotics Corporation’s releases · as of Oct 29, 2026
- Common shares
- 57,536,121
- Fully diluted
- 57,536,121
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 57,536,121 | Oct 29, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 29, 2026 | 57,536,121 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Frederic Moll Other companies: SS Innovations International Inc. (Vice Chairman · Since at least Aug 20, 2024); Lux Health Tech Acquisition Corp (Director · Oct 26, 2020 – Oct 26, 2020 · Past); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past); Venus Concept Inc (Director · Oct 11, 2017 – Nov 7, 2019 · Past); Intersect ENT Inc (Director · Jul 23, 2014 – Jan 19, 2021 · Past); Hansen Medical Inc (Director · Mar 3, 2009 – Mar 1, 2012 · Past) | DIRECTOR · Since at least Sep 14, 2021 |
| Reza Zadno Other companies: Mobia Medical, Inc. (Board Member · Since at least Jul 14, 2026); Invuity Inc (Director · May 19, 2016 – May 3, 2017 · Past); Carbylan Therapeutics Inc (Director · Aug 3, 2015 – Aug 3, 2015 · Past) | President, CEO, Director · Sep 14, 2021 – May 9, 2025 · Past |
| Amy M. Dodrill Other companies: CTS Corporation (Member · Since at least Nov 5, 2026) | DIRECTOR · Since at least Jun 9, 2026 |
| Antal Desai Other companies: Reata Pharmaceuticals Inc (Director · Sep 26, 2023 – Sep 26, 2023 · Past) | DIRECTOR · Since at least Sep 14, 2021 |
| Daniel Puckett Other companies: Shockwave Medical Inc (Chief Financial Officer · Oct 15, 2020 – Feb 5, 2024 · Past) | Director · Since at least Mar 5, 2026 |
| Elisabeth Little Other companies: VYNE Therapeutics Inc. (Director · Since at least Dec 13, 2023) | Director · Since at least Jun 4, 2024 |
| Larry Wood Other companies: Edwards Lifesciences Corporation (Global President TAVR & Surg · Since at least Apr 5, 2022) | PRESIDENT & CHIEF EXECUTIVE OFFICER · Since at least Apr 18, 2024 |
| Mary Garrett Other companies: Omnicell, Inc. (Director · Since at least Jun 1, 2026) | Director · Since at least Jun 9, 2026 |
| Taylor Harris Other companies: Establishment Labs Holdings Inc. (Board Member · Since at least Jun 24, 2026) | Director · Since at least Jun 9, 2026 |
| Thomas M. Krummel Other companies: California Water Service Group (Director · Since at least Jul 1, 2010) | Director · Sep 14, 2021 – Jun 4, 2024 · Past |
All 20 people
| Person | Seat |
|---|---|
| Alaleh Nouri | EVP, CLO, CORP. SEC. · Since at least Jun 8, 2026 |
| Barry L Templin | EVP, Chief Technology Officer · Since at least Apr 16, 2026 |
| Hisham Shiblaq | EVP, Chief Comm. Officer · Since at least Mar 6, 2024 |
| Kevin Waters | Executive VP, Chief Financial Officer · Since at least Feb 19, 2026 |
| Matt Bacso | VP, Investor Relations and Business Operations · Since at least Apr 30, 2026 |
| Matt BacsoVP | Investor Relations and Business · Nov 4, 2025 – Nov 5, 2026 · Past |
| Michael Mack | Director · Since at least Oct 2, 2026 |
| Morgan Colby Wood | Director · Sep 14, 2021 – Nov 13, 2023 · Past |
| Pooja Sharma | Chief Strat/Marketing Officer · Since at least Apr 16, 2026 |
| Thomas M. Prescott | Director · Since at least Jul 24, 2025 |
Log in to ask 6ix AI your own questions about PROCEPT BioRobotics Corporation.